Author

Ashley Zimmerman

Observed name: A. A. Zimmerman

Institutions: Mayo Clinic, Mayo Clinic in Florida

Observed institutions: Mayo Clinic, University of Illinois Chicago, Indiana University Bloomington, Mayo Clinic in Florida, Mayo Clinic Comprehensive Cancer Center (Florida), Indiana University

OpenAlex ID: A5066979779

Hyperpigmentation in Acute Leukemia Treated with Folic Acid Antagonists.

1950 · H. A. Waisman, J. B. Richmond, et al. · Experimental Biology and Medicine · 5

A phase II study of ibrutinib in combination with ixazomib in patients with Waldenström macroglobulinaemia

2024 · Ricardo D. Parrondo, Navnita Dutta, et al. · British Journal of Haematology · 4

Phase II Study of Ibrutinib in Combination with Ixazomib in Patients with Waldenström Macroglobulinemia (WM)

2022 · Sikander Ailawadhi, Ricardo D Parrondo, et al. · Blood · 4

Peri-Transplant and Maintenance Daratumumab for Minimal Residual Disease (MRD) Eradication in Transplant-Eligible Multiple Myeloma (MM) Patients

2022 · Sikander Ailawadhi, Ricardo D Parrondo, et al. · Blood · 2

Time-Limited Maintenance with Ibrutinib after First-Line Therapy and the Incremental Impact on Minimal Residual Disease (MRD) for Patients with Chronic Lymphocytic Leukemia (CLL)

2022 · Sikander Ailawadhi, Ricardo D Parrondo, et al. · Blood · 1

A phase II study of daratumumab and ibrutinib for relapsed/refractory chronic lymphocytic leukemia

2026 · Ricardo D. Parrondo, Sikander Ailawadhi, et al. · Blood Cancer Journal

Madeleine Leonard: The Sociology of Children, Childhood and Generation

2017 · Ashley Zimmerman · Journal of Youth and Adolescence

ITEM: Recognition - McCracken County student athletes who competed in the 2011 KHSAA State Cross Country competition. APPLICABLE BOARD OF EDUCATION POLICY, ADMINISTRATIVE REGULATION OR STATUTE: N/A

2011 · Zach Hudspeth, Bradley J. Baker, et al.

Works count: 8

Citation count: 16

H-index: 3

I10-index: